Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

NBE-Therapeutics

Biotech & Life Sciences · Basel, Switzerland · Founded 2012 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Revenue
$1–10M
Latest reported FY
Unlock exact value
Headcount
<100
Current team size
Unlock exact value

Investors

4 investors on NBE-Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 1 investor entered at this stage
Boehringer Ingelheim Venture Fund
Series B+ 3 investors entered at this stage
PPF Group
Boehringer Ingelheim
Novo Holdings

Global footprint

Where NBE-Therapeutics has talent and traffic

Web traffic by country
3.7K monthly visits
across markets
🇨🇭 Switzerland78.4%
🇬🇧 United Kingdom13.5%
🇩🇪 Germany8.1%
Top 3 markets shown

Patent intelligence

$29M patent portfolio · 14 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$29M
2.2% of valuation · 27× smaller than top peer BioNTech ($780M)
14 active patent families
Where NBE-Therapeutics innovates Molecular biologyBinding proteinPharmaceutical drugEnzymeAntigen binding
Above peer median on Legal, Market, Economic, Technology

Quality vs same-sector peers

NBE-Therapeutics on the five Patsnap quality dimensions

NBE-Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where NBE-Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across NBE-Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See NBE-Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo